$12.50
-0.22 (-1.73%)
Performance
1D
—
1W
—
1M
—
3M
+24.50%
6M
+43.35%
1Y
+29.13%
YTD
+29.13%
Open$12.68
Previous Close$12.72
Day High$12.84
Day Low$12.34
52W High$15.10
52W Low$1.94
Volume—
Avg Volume1.23M
Market Cap882.80M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$9.43
Above
RSI (14)
67.2
Neutral
Analyst Ratings
Strong Buy
13 analysts
Price Target
-4.2% upside
Current
$12.50
$12.50
Target
$11.98
$11.98
$7.05
$11.98 avg
$14.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 163.82M | 157.27M | 158.27M |
| Net Income | -44,702,535 | -44,556,024 | -43,506,106 |
| Profit Margin | -27.3% | -28.3% | -27.5% |
| EBITDA | -45,867,623 | -43,115,764 | -48,402,369 |
| Free Cash Flow | -22,695,190 | -23,234,474 | -24,663,069 |
| Rev Growth | +3.0% | +15.0% | +13.1% |
| Debt/Equity | 0.40 | 0.42 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |